Evidence map›Paper›PMID 42272269›Full record

ArticleJMIR cancer2026

Supporting Patients With Breast Cancer and Providers Through Treatment and Survivorship: Multimethod Implementation Study of the MyJourney Platform.

Isabella Herrington, Julie Makarski, Krystle Amog, Leigh Hayden, Kate Mossman, Norna Abbo, Nicole Jedrzejko, Fahima Osman, Monika Kastner

Abstract read
In one paragraph

Article in JMIR cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Isabella HerringtonResearch and Innovation, North York General Hospital, 4001 Leslie Street, Toronto, ON, M2K 1E1, Canada, 1 416 756 6000.ORCID 0000-0002-7065-8479
Julie MakarskiResearch and Innovation, North York General Hospital, 4001 Leslie Street, Toronto, ON, M2K 1E1, Canada, 1 416 756 6000.ORCID 0009-0007-2689-4013
Krystle AmogInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.ORCID 0000-0001-5553-3195
Leigh HaydenResearch and Innovation, North York General Hospital, 4001 Leslie Street, Toronto, ON, M2K 1E1, Canada, 1 416 756 6000.ORCID 0000-0002-3345-7686
Kate MossmanResearch and Innovation, North York General Hospital, 4001 Leslie Street, Toronto, ON, M2K 1E1, Canada, 1 416 756 6000.ORCID 0000-0002-4309-4778
Norna AbboInstitute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada.ORCID 0009-0000-9739-0006
Nicole JedrzejkoDivision of General Surgery, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-7340-4186
Fahima OsmanDepartment of Surgery, North York General Hospital, Toronto, ON, Canada.ORCID 0000-0002-1041-7497
Monika KastnerResearch and Innovation, North York General Hospital, 4001 Leslie Street, Toronto, ON, M2K 1E1, Canada, 1 416 756 6000.ORCID 0000-0002-2838-7417

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breast cancer is the most common cancer among Canadian women, bringing complex demands for timely decision-making, coordination of multidisciplinary care, and efficient communication between patients and providers. The increasing reliance on fragmented and noninteroperable health information systems exacerbates workflow and documentation burdens, leading to inefficiencies and gaps in continuity of care. While nurse navigation programs partially bridge these gaps, most digital platforms remain poorly integrated into provider workflows, requiring manual tracking, which results in duplicated effort and reduced efficiency. Our team developed "MyJourney" at North York General Hospital (NYGH) in Ontario. It is a digital navigation platform that supports breast cancer care throughout the entire continuum, from diagnosis to survivorship. Objective: This study aimed (1) to map the breast cancer journey and workflow to inform the design and adaptation of MyJourney at 2 oncology settings at NYGH; (2) to identify barriers and guide local implementation; and (3) to evaluate the implementation, usability, and perceived utility of MyJourney's Clinical Navigation Tool for breast cancer care teams. Methods: A multimethod, 3-phase study was conducted at NYGH's Breast Diagnostic Centre (BDC) and Chemotherapy Clinic (CC) in Toronto, Canada. Phase 1 involved qualitative interviews with patients with breast cancer to map their care journey and inform user-centered platform design. Phase 2 included preimplementation interviews with nurses, pharmacists, and administrative staff to map workflows and customize MyJourney for the CC. Phase 3 evaluated MyJourney's implementation and usability over 6 weeks using the System Usability Scale, technology acceptance model surveys, and follow-up interviews with platform users. Data were analyzed via interpretive description and descriptive statistics. Ethics approval was obtained. Results: In total, 13 patient interviews revealed distinct challenges and communication needs across prediagnosis, diagnosis, treatment, and survivorship phases, emphasizing the need for personalized, integrated resources (phase 1). A total of 8 participants (3 nurses and 5 pharmacists), providers, and clinic staff highlighted pain points in fragmented information systems, inefficient manual processes, and limited team coordination (phase 2). MyJourney's phased implementation led to high user acceptance, with mean System Usability Scale scores rated "excellent" (BDC: 81.3; CC: 86.3) at the 6-week follow-up (phase 3). The 4 participants (1 charge nurse, 1 administrative staff at the BDC, and 2 charge nurses at the CC) described the platform as intuitive, efficient, and well-organized, citing consolidated patient records, streamlined appointment management, and improved workflow as major benefits. Recommendations included improved interoperability, enhanced notifications, role-specific customization, and integration with electronic medical records for broader scalability. Conclusions: The iterative, interest-holder engaged design and phased implementation of MyJourney facilitated rapid uptake and high usability among breast cancer provider teams. The Clinical Navigation Tool component of the MyJourney platform reduced documentation burden, improved workflow efficiency, and facilitated care coordination across oncology settings.

Indexed as

Breast NeoplasmsPatient NavigationAdultAgedContinuity of Patient CareFemaleHumansMiddle AgedOntarioSurvivorshipWorkflowbreast cancerimplementationpatient journeyqualitative methodsusability testing

Identifiers

PMID42272269
PMCPMC13254169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.